Lexent Bio
is a biotechnology company that researches and develops novel liquid biopsy system to diagnose and treat cancer... Read moreLexent Bio
is a biotechnology company that researches and develops novel liquid biopsy system to diagnose and treat cancer... Read more
News
Jun 17, 2020
Los Angeles Citybizlist
Lexent Bio: Foundation Medicine Acquires Lexent Bio
Jun 12, 2020
Genomeweb
Lexent Bio: Foundation Medicine Acquires Lexent Bio to Expand Liquid Biopsy Platforms
May 14, 2020
PR Newswire
Press Release: Lexent Bio : Lexent Bio Announces Use of its Liquid Biopsy Assay, Confera Dx, in a Peer-Reviewed Paper Published in the Journal Molecular Cancer Therapeutics
Nov 11, 2019
BioPortfolio
Lexent Bio: Lexent Bio partners with Illumina to develop in vitro diagnostic kit
Nov 08, 2019
Genomeweb
Lexent Bio: Illumina, Lexent Partner on NGS-Based Cancer IVD Kit
Nov 08, 2019
BioSpace
Lexent Bio: Lexent Bio Enters Partnership with Illumina to Develop an In Vitro Diagnostic Kit
Sep 28, 2018
Genomeweb
Lexent Bio: Lexent Bio Joins Push to Develop Liquid Biopsy Tech for Cancer Treatment Monitoring
Lexent Bio Competitors
1
2
3
4
5
6
7
8
9
10